Vivint Pharma Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 06-11-2024
- Paid Up Capital ₹ 21.00 Cr
as on 06-11-2024
- Company Age 2 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
About Vivint Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 21.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nagesh Middey, Raghuveer Adusumilli, and Venkata Jagarlamudi serve as directors at the Company.
- CIN/LLPIN
U24299TG2022PTC165671
- Company No.
165671
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2022
- Date of AGM
26 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vivint Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagesh Middey  | Managing Director | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raghuveer Adusumilli | Whole-Time Director | Current | |
| Venkata Jagarlamudi | Director | Current |
Financial Performance of Vivint Pharma.
Enhance accessibility to Vivint Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vivint Pharma?
Unlock access to Vivint Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Questus Pharma Private LimitedActive 3 years 4 monthsNagesh Middey, Raghuveer Adusumilli and 1 more are mutual person
Halsted Pharma Private LimitedActive 2 years 3 monthsNagesh Middey, Raghuveer Adusumilli and 1 more are mutual person
- Prathyak Laboratories Private LimitedActive 2 years 3 months
Nagesh Middey, Raghuveer Adusumilli and 1 more are mutual person
- Coley Pharma Private LimitedActive 2 years 1 month
Nagesh Middey and Venkata Jagarlamudi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vivint Pharma?
Vivint Pharma has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivint Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivint Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
